March 18, 2020 / 10:23 PM / 23 days ago

BRIEF-Acer Therapeutics Receives Formal Dispute Resolution Request (Fdrr) Response From FDA's Office Of New Drugs

March 18 (Reuters) - Acer Therapeutics Inc:

* ACER THERAPEUTICS INC - RECEIVES FORMAL DISPUTE RESOLUTION REQUEST (FDRR) RESPONSE FROM FDA’S OFFICE OF NEW DRUGS

* ACER THERAPEUTICS - FDA’S OFFICE OF NEW DRUGS HAS DENIED ACER’S APPEAL OF COMPLETE RESPONSE LETTER IN RELATION TO NDA FOR EDSIVO

* ACER THERAPEUTICS - EVALUATING POSSIBLE NEXT STEPS WITH GOAL OF RESUBMISSION OF EDSIVO NDA

* ACER THERAPEUTICS - BELIEVES CASH POSITION WILL BE SUFFICIENT TO FUND ITS CURRENT OPERATIONS THROUGH END OF 2020, EXCLUDING SOME ACTIVITIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below